Isolated T-cell receptor, cells modified therefor, encoding nucleic acid, expression vector, preparation method, pharmaceutical composition and application
A technology of cell receptors and nucleic acids, applied in the biological field, to achieve the effect of avoiding off-target toxic and side effects
- Summary
- Abstract
- Description
- Claims
- Application Information
 AI Technical Summary 
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0139] Preparation of recombinant TCR lentiviral expression vector: The viral vector used to express TCR is a replication-defective lentiviral vector, including: GFP-expressing lentiviral vector pCDH-EF1α-MCS-(PGK-GFP), which can be purchased from System Biosciences (Cat#CD811A-1); and the vector pCDH-EF1α-MCS that does not express GFP, obtained by removing the PGK promoter and GFP gene on the pCDH-EF1α-MCS-(PGK-GFP) vector using conventional techniques in the art. According to the obtained TCR gene sequence, synthesize the entire gene sequence of TCR β chain and α chain and the cleavable F2A sequence and Furin restriction fragment in between, and link to the multiple cloning site downstream of the EF-1α promoter of the vector , the transcription sequence inserted into TCR is TCRβ chain (without stop codon), Furin digestion fragment, F2A fragment, TCRα chain (for the method, see the document "Gene Ther. 2008 Nov; 15(21): 1411-1423"). The GFP expressing vector is driven by the ...
Embodiment 1
[0142] Example 1: Induction of Her2 / neu 369-377 polypeptide-specific killer T cells from HLA-A2 positive normal donor peripheral blood
[0143] In this example, a low concentration of 1 μg / ml Her2 / neu 369-377 polypeptide was used to induce polypeptide-specific killer T cells from normal PBMC (#2PBMC) after two rounds of in vitro stimulation, and flow cytometry analysis and single cell isolation were performed. The specific method is as described above. The result is as follows:
[0144] figure 1 A Right panel shows that 0.013% of lymphocytes are CD8 positive killer T cells that can bind Her2 / neu 369-377 / HLA-A2 pentamer (ie Her2-E75 pentamer), left panel is not stimulated by Her2 polypeptide of control cells did not appear CD8-positive pentamer-positive cells. The results indicated that the number of specific T cells recognizing the Her2 / neu 369-377 antigen polypeptide was very small in the natural T cell pool. Despite their small numbers, this population of T cells recogni...
Embodiment 2
[0145] Example 2: Acquisition and identification of the full sequence of Her2 / neu 369-377 polypeptide-specific TCR
[0146] This example obtained directly from the Her2 / neu 369-377 polypeptide-specific CTL clone obtained in Example 1, a CTL comprising matching alpha and beta chains (ie, the two chains could together constitute a functional TCR that recognizes the antigenic polypeptide) The complete TCR gene sequence, the encoded TCR is called "Her2 TCR-1B5". The amino acid sequence of the α chain of the TCR is shown in SEQ ID NO: 2, the coding sequence is shown in SEQ ID NO: 1, and the amino acid sequence of the β chain of the TCR is shown in SEQ ID NO: 4, and the coding sequence is shown in SEQ ID NO: 4 ID NO:3. This TCR exists in the peripheral T cell pool of HLA-A2-positive normal people, and will not cross-react with normal cells expressing Her2 / neu protein at a small amount, resulting in autoimmune reactions. The specific detection method is as described above. The res...
PUM
 Login to View More
 Login to View More Abstract
Description
Claims
Application Information
 Login to View More
 Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com



